Health Care: Drugs

Meridian Bioscience Inc (VIVO: NASDAQ)

$16.96 n/a | n/a%
12/19/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 16.96
52 Week High 27.72
52 Week Low 15.80
Avg. Daily Vol. (Mil) 0.28
Beta (3 year) 1.29
Share Related Items
Mkt Cap (Mil) 706.71
Shares Out (Mil) 41.64
Float (Mil) 36.56
Dividend Information
Yield % 4.70
Annual Dividend 0.80
Payout Ratio 95.00
Financial Strength
Quick Ratio 4.80
Current Ratio 8.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 20.50
Price/Sales 3.74
Price/Book 4.39
Price/Cash Flow 16.80
Per Share Data
Earnings 0.83
Sales 4.53
Book Value 3.87
Cash Flow 1.01
Business Summary
Meridian Bioscience Inc is an integrated life science company. It is engaged in development, manufacture, sale and distribution of diagnostic test kits for certain gastrointestinal, viral, respiratory and parasitic infectious diseases.
General Information
3471 River Hills Drive
Cincinnati, OH 45244
www.meridianbioscience.com
Industry : Drugs
Sector: Health Care
Employees: 550
CEO: John A. Kraeutler
Short Interest
Current Month (Mil) 6.04
Previous Month (Mil) 6.81
Short Interest Ratio (Days) 17.10
Management Effectiveness
Return on Equity 21.60
Return on Assets 19.60
Return on Investments 21.60
Profitability
Gross Margin 65.90
EBIT Margin 27.60
Profit Margin 18.40

Portfolios with VIVO

Latest VIVO Headlines from TheStreet

More Financial News for VIVO

Press Releases for VIVO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter